Biogen's Fampyra Launched in Canada Zacks.com Besides BG-12, Biogen is developing other multiple sclerosis candidates like daclizumab, in partnership with Abbott Labs (ABT), and PEGylated interferon. Biogen recently signed an exclusive, worldwide option and collaboration agreement with privately ... |
